Companies: 10,795·Total market cap: $144.5T

Indaptus Therapeutics, Inc.

Indaptus Therapeutics, Inc.

INDPNASDAQHealthcare● Active

$2.10

$-1.56(-42.62%)

Market Cap$3677138

P/E Ratio—

52W High$19.908

52W Low$0.92

Avg Volume68K

Open$3.52

Beta1.27

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Indaptus Therapeutics, Inc.（INDP）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · INDP · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-6.34Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding966,124Shares outstanding history

Next EarningsAug 17, 2026Est.Earnings history

探索 Indaptus Therapeutics, Inc. 数据

分析师预测$— · Buy

股息不分红

盈利EPS $-21.58-1240.37%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$20.8M▼ 38.79% YoY

202320242025

FY 2025EPS$-21.58▼ 1240.37% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$18.9MEPS: $-6.34View income statement →

分析师评级与目标价

Buy2 位分析师

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$2.10Current

$—Avg Target

$—High

合计: 2 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Indaptus Therapeutics, Inc.

$2.10-42.62%$3.7M #2

Avenue Therapeutics, Inc.

$0.31-12.06%$1.0M #3

$0.20-3.24%$2.2M #4

GT Biopharma, Inc.

$0.43-2.57%$4.5M #5

Lipella Pharmaceuticals Inc.

$0.10-4.76%$462,084 #6

NKGen Biotech, Inc. Common Stock

$0.06+0.00%$7.8M

股票表现

1D-42.62%

1W-2.78%

1M+11.70%

3M+13.51%

YTD-27.84%

1Y-78.10%

5Y-99.51%

关于 Indaptus Therapeutics, Inc.

CEOJunyi Dai

IPO DateAug 4, 2015

Employees7

CountryUS

Websiteindaptusrx.com

Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral inf…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Indaptus Therapeutics, Inc.（INDP）是 Biotechnology 行业的 Healthcare 类公司，于 Aug 4, 2015 在 NASDAQ 上市。截至最近交易日，INDP 股价为 $2.10，市值约为 $3.7M。过去12个月累计回报 -78.10%，年初至今回报 -27.84%。

根据 2 位华尔街分析师，Indaptus Therapeutics, Inc. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 Indaptus Therapeutics, Inc. 营收 —，净利润 -$20.8M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Indaptus Therapeutics, Inc.（INDP）股价为 $2.10，在 NASDAQ 上市，52周区间为 $0.92 – $19.91。

INDP 最新股价INDP quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议